Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin.
about
Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Using a Systems Pharmacology Model of the Blood Coagulation Network to Predict the Effects of Various Therapies on BiomarkersApplication of Adaptive DP-optimality to Design a Pilot Study for a Clotting Time Test for Enoxaparin.An Evaluation of a Factor Xa-Based Clotting Time Test for Enoxaparin: A Proof-of-Concept Study.
P2860
Development and evaluation of a prototype of a novel clotting time test to monitor enoxaparin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Development and evaluation of ...... me test to monitor enoxaparin.
@en
Development and evaluation of ...... me test to monitor enoxaparin.
@nl
type
label
Development and evaluation of ...... me test to monitor enoxaparin.
@en
Development and evaluation of ...... me test to monitor enoxaparin.
@nl
prefLabel
Development and evaluation of ...... me test to monitor enoxaparin.
@en
Development and evaluation of ...... me test to monitor enoxaparin.
@nl
P2860
P1476
Development and evaluation of ...... me test to monitor enoxaparin.
@en
P2093
Abhishek Gulati
James M Faed
P2860
P304
P356
10.1007/S11095-011-0537-Z
P577
2011-08-06T00:00:00Z